Channing Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-59,823
| Closed | -$6.47M | – | 128 |
|
|
2019
Q4 | $6.47M | Sell |
59,823
-19,281
| -24% | -$2.09M | 0.3% | 95 |
|
|
2019
Q3 | $7.75M | Buy |
79,104
+7,816
| +11% | +$765K | 0.36% | 78 |
|
|
2019
Q2 | $9.34M | Buy |
71,288
+2,666
| +4% | +$349K | 0.43% | 58 |
|
|
2019
Q1 | $9.28M | Sell |
68,622
-26,659
| -28% | -$3.6M | 0.43% | 53 |
|
|
2018
Q4 | $9.28M | Sell |
95,281
-1,624
| -2% | -$158K | 0.46% | 50 |
|
|
2018
Q3 | $13.5M | Sell |
96,905
-3,285
| -3% | -$457K | 0.49% | 41 |
|
|
2018
Q2 | $12.4M | Sell |
100,190
-17,883
| -15% | -$2.22M | 0.44% | 48 |
|
|
2018
Q1 | $13.2M | Sell |
118,073
-7,205
| -6% | -$803K | 0.46% | 56 |
|
|
2017
Q4 | $15M | Buy |
+125,278
| New | +$15M | 0.51% | 53 |
|
|
2017
Q2 | – | Sell |
-96,533
| Closed | -$11.7M | – | 109 |
|
|
2017
Q1 | $11.7M | Buy |
96,533
+1,332
| +1% | +$161K | 0.43% | 62 |
|
|
2016
Q4 | $11.6M | Buy |
+95,201
| New | +$11.6M | 0.41% | 63 |
|